HPV overtakes smoking as the leading cause of oropharyngeal cancer in Ireland: experience of a head and neck surgery tertiary referral centre

被引:1
作者
Cleere, Eoin F. [1 ]
Murphy, Josh [1 ]
Crotty, Thomas J. [1 ]
Hintze, Justin M. [1 ]
Timon, Conrad V. I. [1 ]
Kinsella, John [1 ]
Fitzgerald, Conall W. R. [1 ]
Lennon, Paul [1 ]
机构
[1] St James Hosp, Dept Otolaryngol Head & Neck Surg, Dublin, Ireland
关键词
Epidemiology; HPV; Human papillomavirus; Oropharyngeal cancer; Squamous cell carcinoma; HUMAN-PAPILLOMAVIRUS; SURVIVAL; EPIDEMIOLOGY; PREDICTORS; RATES;
D O I
10.1007/s11845-024-03715-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Worldwide, the incidence of oropharyngeal squamous cell carcinoma (OPSCC) caused by human papillomavirus (HPV), a sexually transmitted virus, is increasing. This increase has yet to be demonstrated in an Irish cohort. Aims To evaluate the number of OPSCC presentations locally, to stratify cases by HPV status and to estimate if any changes in the patient population had occurred over a 10-year period. Methods A STROBE-compliant, retrospective evaluation of patients with OPSCC at St James's Hospital between 2012 and 2022 was performed. Patients with non-SCC histology, undocumented HPV status and residual or recurrent tumours were excluded. Results We included 294 patients with a mean age of 60.4 years (95% CI 59.2-61.5 years) and 175 (59.5%) patients had HPV+ OPSCC. The number of new OPSCC diagnoses increased from 115 patients (39.1%) between 2012 and 2016 to 179 patients (60.9%) between 2017 and 2021. This was associated with an increased proportion of HPV-linked OPSCC (50.4% 2012-2016 vs. 65.4% 2017-2021, p = 0.011). Over time, more patients had a functionally limiting comorbidity (p = 0.011). The mean age of HPV+ OPSCC cases increased by 3.6 years (p = 0.019). Patients with HPV+ OPSCC had greater 2-year OS (83.9% vs. 54.9%; p < 0.001) and 2-year DFS (73.5% vs. 45.6%; p < 0.001). The 2-year OS and DFS did not change over time for HPV+ or HPV- patients. Conclusions In our institution, the number of patients with OPSCC is increasing due to an escalation in cases associated with HPV. Population-level interventions such as vaccination programs may alter the current increase in the incidence of these tumours.
引用
收藏
页码:2161 / 2169
页数:9
相关论文
共 31 条
[1]   Utility of p16 andHPVtesting in oropharyngeal squamous cell carcinoma: An institutional review [J].
Abdelhakam, Dina A. ;
Huenerberg, Katherine A. ;
Nassar, Aziza .
DIAGNOSTIC CYTOPATHOLOGY, 2021, 49 (01) :54-59
[2]   Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base [J].
Amini, Arya ;
Jasem, Jagar ;
Jones, Bernard L. ;
Robin, Tyler P. ;
McDermott, Jessica D. ;
Bhatia, Shilpa ;
Raben, David ;
Jimeno, Antonio ;
Bowles, Daniel W. ;
Karam, Sana D. .
ORAL ONCOLOGY, 2016, 56 :1-7
[3]   Predictors of oropharyngeal cancer survival in Europe [J].
Anantharaman, D. ;
Billot, A. ;
Waterboer, T. ;
Gheit, T. ;
Abedi-Ardekani, B. ;
Lagiou, P. ;
Lagiou, A. ;
Ahrens, W. ;
Holcatova, I. ;
Merletti, F. ;
Kjaerheim, K. ;
Polesel, J. ;
Simonato, L. ;
Alemany, L. ;
Cervigon, M. Mena ;
Macfarlanene, T. V. ;
Znaor, A. ;
Thomson, P. J. ;
Robinson, M. ;
Canova, C. ;
Conway, D. I. ;
Wright, S. ;
Healy, C. M. ;
Toner, M. E. ;
Pawlita, M. ;
Tommasino, M. ;
Brennan, P. .
ORAL ONCOLOGY, 2018, 81 :89-94
[4]   Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer [J].
Ang, K. Kian ;
Harris, Jonathan ;
Wheeler, Richard ;
Weber, Randal ;
Rosenthal, David I. ;
Nguyen-Tan, Phuc Felix ;
Westra, William H. ;
Chung, Christine H. ;
Jordan, Richard C. ;
Lu, Charles ;
Kim, Harold ;
Axelrod, Rita ;
Silverman, C. Craig ;
Redmond, Kevin P. ;
Gillison, Maura L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (01) :24-35
[5]   Rising Trend in the Prevalence of HPV-Driven Oropharyngeal Squamous Cell Carcinoma during 2000-2022 in Northeastern Italy: Implication for Using p16INK4a as a Surrogate Marker for HPV-Driven Carcinogenesis [J].
Boscolo-Rizzo, Paolo ;
Polesel, Jerry ;
Del Mistro, Annarosa ;
Fratta, Elisabetta ;
Lazzarin, Chiara ;
Menegaldo, Anna ;
Lupato, Valentina ;
Fanetti, Giuseppe ;
Zanconati, Fabrizio ;
Guido, Maria ;
Giacomarra, Vittorio ;
Emanuelli, Enzo ;
Tofanelli, Margherita ;
Tirelli, Giancarlo .
CANCERS, 2023, 15 (09)
[6]   Burden of HPV-positive oropharynx cancers among ever and never smokers in the US population [J].
Chaturvedi, Anil K. ;
D'Souza, Gypsyamber ;
Gillison, Maura L. ;
Katki, Hormuzd A. .
ORAL ONCOLOGY, 2016, 60 :61-67
[7]   Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers [J].
Chaturvedi, Anil K. ;
Anderson, William F. ;
Lortet-Tieulent, Joannie ;
Curado, Maria Paula ;
Ferlay, Jacques ;
Franceschi, Silvia ;
Rosenberg, Philip S. ;
Bray, Freddie ;
Gillison, Maura L. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (36) :4550-4559
[8]   Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States [J].
Chaturvedi, Anil K. ;
Engels, Eric A. ;
Pfeiffer, Ruth M. ;
Hernandez, Brenda Y. ;
Xiao, Weihong ;
Kim, Esther ;
Jiang, Bo ;
Goodman, Marc T. ;
Sibug-Saber, Maria ;
Cozen, Wendy ;
Liu, Lihua ;
Lynch, Charles F. ;
Wentzensen, Nicolas ;
Jordan, Richard C. ;
Altekruse, Sean ;
Anderson, William F. ;
Rosenberg, Philip S. ;
Gillison, Maura L. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4294-4301
[9]   Worldwide burden of cancer attributable to HPV by site, country and HPV type [J].
de Martel, Catherine ;
Plummer, Martyn ;
Vignat, Jerome ;
Franceschi, Silvia .
INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (04) :664-670
[10]   Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial [J].
Fakhry, Carole ;
Westra, William H. ;
Cmelak, Sigui Li Anthony ;
Ridge, John A. ;
Pinto, Harlan ;
Forastiere, Arlene ;
Gillison, Maura L. .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (04) :261-269